Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

about

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

Item

http://www.wikidata.org/entity/Q49169182

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@en

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@nl

type

Item

label

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@en

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@nl

prefLabel

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@en

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@nl

P1476

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation.

@en

P2093

Alice Bertaina

http://www.w3.org/2001/XMLSchema#string

Pietro Merli

http://www.w3.org/2001/XMLSchema#string

P2860

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre t

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

P304

96460-96461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.18632/ONCOTARGET.20878

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franco Locatelli

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29228536

http://www.w3.org/2001/XMLSchema#string

P932

5722488

http://www.w3.org/2001/XMLSchema#string